{
    "2018-07-23": [
        [
            {
                "time": "",
                "original_text": "陈发树出任白药控股董事长 云南白药董事会今年将换届",
                "features": {
                    "keywords": [
                        "陈发树",
                        "白药控股",
                        "董事长",
                        "换届"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "9年恩怨，多次败诉，254亿收购！这位黄金富豪终于当上了百年医药巨头董事长",
                "features": {
                    "keywords": [
                        "陈发树",
                        "收购",
                        "医药",
                        "董事长"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "福建前首富陈发树254亿入股云南白药 出任董事长",
                "features": {
                    "keywords": [
                        "陈发树",
                        "云南白药",
                        "入股",
                        "董事长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "“疫苗风暴”未平！长生生物午后复牌跌停，医药股集体大跌",
                "features": {
                    "keywords": [
                        "疫苗风暴",
                        "长生生物",
                        "跌停",
                        "医药股"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "南卫股份拟两步收购标的资产 是否规避借壳遭质疑",
                "features": {
                    "keywords": [
                        "南卫股份",
                        "收购",
                        "借壳",
                        "质疑"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：建议关注低估值、预期改善的医药流通板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "增持评级",
                        "低估值",
                        "医药流通"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北向资金持续加仓 A股配置价值凸显",
                "features": {
                    "keywords": [
                        "北向资金",
                        "加仓",
                        "A股",
                        "配置价值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}